Vanguard Group Discloses Position in Spire Healthcare

On September 30, 2025, The Vanguard Group, Inc. released a Form 8.3, disclosing their position in Spire Healthcare Group plc. Vanguard's substantial interest is highlighted by its ownership of 3.59% of Spire's ordinary shares. This disclosure is in compliance with Rule 8.3 of the Takeover Code and reflects Vanguard's ongoing engagement with relevant securities constituting 1% or more.

Vanguard has acquired 3,223 additional Spire shares at a price of 2.49 GBP per share. The disclosure does not involve any indemnity, option agreements, or other inducements. There are also no existing agreements relating to the voting rights of these securities. No further attachments or Supplementary Form 8 were included in the disclosure.